Acquired neuromuscular disorders (NMDs) encompass a broad spectrum of conditions affecting the peripheral nerves, muscles, and neuromuscular junctions that are not inherited genetically but rather developed through life . These disorders often stem from inflammatory, autoimmune, or toxic triggers, becoming increasingly prevalent in aging populations due to factors like medication side effects (e.g., statins) or paraneoplastic syndromes. Pathogenesis of Acquired NMDs

: The immune system mistakenly targets structural proteins. For instance, in Myasthenia Gravis , autoantibodies (such as AChR or MuSK) damage acetylcholine receptors, blocking the signals between nerves and muscles.

: Electromyography (EMG) and nerve conduction studies are used to distinguish between primary muscle issues (myopathies) and nerve issues (neuropathies).

: Certain drugs, such as statins or cancer treatments, can induce Statin Myopathies or toxic neuropathies by interfering with cellular metabolism or inducing oxidative stress.

: Managing symptoms through medication, such as anticholinesterase agents for Myasthenia Gravis.

: Cancer-related immune responses can cross-react with neuromuscular components, leading to specialized paraneoplastic syndromes. Diagnostic Framework

: Disorders like Polymyositis involve direct inflammatory infiltration of muscle tissue, leading to fiber degeneration.

: Identifying specific autoantibodies is crucial for confirming autoimmune NMDs like Myasthenia Gravis.